The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

Kidney disease is a growing health concern in Australia, with many people unaware that they are affected. According to ...

Nearly all children with ANCA-associated vasculitis demonstrate active kidney disease at diagnosis, and their renal function ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

A study showed notable differences in bone mineral density between children on steroids and those not on steroids, with 84% ...